MediWound (MDWD) Common Equity (2013 - 2025)

MediWound's Common Equity history runs 13 years deep, the most recent figure standing at $43.6 million for Q4 2025.

• In Q4 2025, Common Equity rose 40.06% year-over-year to $43.6 million; the TTM figure through Dec 2025 stood at $43.6 million (up 40.06% YoY), while the FY2025 annual figure was $43.6 million, up 40.06% from the prior year.
• Common Equity was $43.6 million for Q4 2025 at MediWound, down from $50.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $50.2 million in Q3 2025 to a low of -$4.6 million in Q4 2021.
• Historically, Common Equity has averaged $19.9 million across 5 years, with a median of $21.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Common Equity plunged 205.52% in 2022, then jumped 1895.77% in 2023.
• A 5-year view of Common Equity shows it stood at -$4.6 million in 2021, then surged by 338.19% to $10.9 million in 2022, then jumped by 189.49% to $31.6 million in 2023, then slipped by 1.4% to $31.2 million in 2024, then jumped by 40.06% to $43.6 million in 2025.
• The last three Common Equity figures came in at $43.6 million (Q4 2025), $50.2 million (Q3 2025), and $20.1 million (Q2 2025), per Business Quant data.